ADVISORY RESEARCH INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$217,553
-82.9%
4,332
-68.7%
0.03%
+30.4%
Q1 2018$1,269,000
-21.7%
13,834
-35.6%
0.02%
-14.8%
Q4 2017$1,620,000
+36.2%
21,480
+25.9%
0.03%
+42.1%
Q3 2017$1,189,000
-13.5%
17,065
-37.1%
0.02%
-13.6%
Q2 2017$1,375,00027,1370.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders